Form 4: Boston Scientific SVP, GC and Corp. Secretary Vance R. Brown Reports Stock Sale

Vance R. Brown, SVP, GC and Corp. Secretary of Boston Scientific, reports the sale of 4,826 shares of common stock at a price of $95.09 per share on April 21, 2025, under a pre-established Rule 10b5-1 trading plan.

Summary

• On April 21, 2025, Vance R. Brown, the SVP, GC and Corp. Secretary of Boston Scientific, sold 4,826 shares of Boston Scientific common stock.
• The sale was executed at a price of $95.09 per share.
• Following the transaction, Brown directly owns 36,193 shares of Boston Scientific common stock.
• The transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on November 21, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard disclosure of an insider stock sale under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider trading activity. It provides transparency to the market regarding the transactions of company executives.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a pre-established trading plan mitigates this concern.

Key Dates

Keywords

Form 4, Boston Scientific, BSX, Vance R. Brown, Stock Sale, Rule 10b5-1, Insider Trading